Therapeutic impacts of GNE‑477‑loaded H2O2 stimulus‑responsive dodecanoic acid‑phenylborate ester‑dextran polymeric micelles on osteosarcoma

Pan,Songmu; Zou,Zhuan; Zhou,Xiaofeng; Wei,Jiyong; Liu,Huijiang; Su,Zhongyi; Liao,Gui; Huang,Guangyu; Huang,Zonggui; Xu,Yi; Lu,Minan; Gu,Ronghe

doi:10.3892/ijmm.2024.5393

Therapeutic impacts of GNE‑477‑loaded H2O2 stimulus‑responsive dodecanoic acid‑phenylborate ester‑dextran polymeric micelles on osteosarcoma

Authors:
- Songmu Pan
- Zhuan Zou
- Xiaofeng Zhou
- Jiyong Wei
- Huijiang Liu
- Zhongyi Su
- Gui Liao
- Guangyu Huang
- Zonggui Huang
- Yi Xu
- Minan Lu
- Ronghe Gu
View Affiliations

Affiliations: Department of Orthopedic Surgery, The First People's Hospital of Nanning, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530022, P.R. China, Department of Pharmacy, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Orthopedic Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China
Published online on: June 27, 2024 https://doi.org/10.3892/ijmm.2024.5393
Article Number: 69
Copyright: © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma (OS) is a highly malignant primary bone neoplasm that is the leading cause of cancer‑associated death in young people. GNE‑477 belongs to the second generation of mTOR inhibitors and possesses promising potential in the treatment of OS but dose tolerance and drug toxicity limit its development and utilization. The present study aimed to prepare a novel H₂O₂ stimulus‑responsive dodecanoic acid (DA)‑phenylborate ester‑dextran (DA‑B‑DEX) polymeric micelle delivery system for GNE‑477 and evaluate its efficacy. The polymer micelles were characterized by morphology, size and critical micelle concentration. The GNE‑477 loaded DA‑B‑DEX (GNE‑477@DBD) tumor‑targeting drug delivery system was established and the release of GNE‑477 was measured. The cellular uptake of GNE‑477@DBD by three OS cell lines (MG‑63, U2OS and 143B cells) was analyzed utilizing a fluorescent tracer technique. The hydroxylated DA‑B was successfully grafted onto dextran at a grafting rate of 3%, suitable for forming amphiphilic micelles. Following exposure to H₂O₂, the DA‑B‑DEX micelles ruptured and released the drug rapidly, leading to increased uptake of GNE‑477@DBD by cells with sustained release of GNE‑477. The in vitro experiments, including MTT assay, flow cytometry, western blotting and RT‑qPCR, demonstrated that GNE‑477@DBD inhibited tumor cell viability, arrested cell cycle in G1 phase, induced apoptosis and blocked the PI3K/Akt/mTOR cascade response. In vivo, through the observation of mice tumor growth and the results of H&E staining, the GNE‑477@DBD group exhibited more positive therapeutic outcomes than the free drug group with almost no adverse effects on other organs. In conclusion, H₂O₂‑responsive DA‑B‑DEX presents a promising delivery system for hydrophobic anti‑tumor drugs for OS therapy.

View Figures

View References

1	Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, et al: Survival and prognosis with osteosarcoma: Outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 109:36–50. 2019. View Article : Google Scholar : PubMed/NCBI
2	Harrison DJ, Geller DS, Gill JD, Lewis VO and Gorlick R: Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018. View Article : Google Scholar
3	Heymann MF, Brown HK and Heymann D: Drugs in early clinical development for the treatment of osteosarcoma. Expert Opin Investig Drugs. 25:1265–1280. 2016. View Article : Google Scholar : PubMed/NCBI
4	Anderson ME: Update on survival in osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar
5	Xu Y, Qi J, Sun W, Zhong W and Wu H: Therapeutic effects of zoledronic Acid-loaded hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite nanoparticles on osteosarcoma. Front Bioeng Biotechnol. 10:8976412022. View Article : Google Scholar : PubMed/NCBI
6	Zhao X, Wu Q, Gong X, Liu J and Ma Y: Osteosarcoma: A review of current and future therapeutic approaches. Biomed Eng Online. 20:242021. View Article : Google Scholar : PubMed/NCBI
7	Liu J, Yao Q, Peng Y, Dong Z, Tang L, Su X, Liu L, Chen C, Ramalingam M and Cheng L: Identification of Small-molecule inhibitors for osteosarcoma targeted therapy: Synchronizing in silico, in vitro, and in vivo analyses. Front Bioeng Biotechnol. 10:9211072022. View Article : Google Scholar : PubMed/NCBI
8	Meng D, Frank AR and Jewell JL: mTOR signaling in stem and progenitor cells. Development. 145:dev1525952018. View Article : Google Scholar : PubMed/NCBI
9	Costa RLB, Han HS and Gradishar WJ: Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: A review. Breast Cancer Res Treat. 169:397–406. 2018. View Article : Google Scholar : PubMed/NCBI
10	Zhou Q, Deng Z, Zhu Y, Long H, Zhang S and Zhao J: mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis. Med Oncol. 27:1239–1245. 2010. View Article : Google Scholar
11	Miwa S, Sugimoto N, Yamamoto N, Shirai T, Nishida H, Hayashi K, Kimura H, Takeuchi A, Igarashi K, Yachie A, et al: Caffeine induces apoptosis of osteosarcoma cells by inhibiting AKT/mTOR/S6K, NF-κB and MAPK pathways. Anticancer Res. 32:3643–3649. 2012.PubMed/NCBI
12	Zhuo BB, Zhu LQ, Yao C, Wang XH, Li SX, Wang R, Li Y and Ling ZY: ADCK1 is a potential therapeutic target of osteosarcoma. Cell Death Dis. 13:9542022. View Article : Google Scholar : PubMed/NCBI
13	Heffron TP, Berry M, Castanedo G, Chang C, Chuckowree I, Dotson J, Folkes A, Gunzner J, Lesnick JD, Lewis C, et al: Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor. Bioorg Med Chem Lett. 20:2408–2411. 2010. View Article : Google Scholar : PubMed/NCBI
14	Ye X, Ruan JW, Huang H, Huang WP, Zhang Y and Zhang F: PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo. Aging (Albany NY). 12:9489–9499. 2020. View Article : Google Scholar : PubMed/NCBI
15	Wang Y, Shen H, Sun Q, Zhao L, Liu H, Ye L, Xu Y, Cai J, Li Y, Gao L, et al: The new PI3K/mTOR inhibitor GNE-477 inhibits the malignant behavior of human glioblastoma cells. Front Pharmacol. 12:6595112021. View Article : Google Scholar : PubMed/NCBI
16	Barber NA and Ganti AK: Pulmonary toxicities from targeted therapies: A review. Target Oncol. 6:235–243. 2011. View Article : Google Scholar : PubMed/NCBI
17	Ulbrich K, Hola K, Subr V, Bakandritsos A, Tucek J and Zboril R: Targeted drug delivery with polymers and magnetic nanoparticles: Covalent and noncovalent approaches, release control, and clinical studies. Chem Rev. 116:5338–5431. 2016. View Article : Google Scholar : PubMed/NCBI
18	MacEwan SR, Callahan DJ and Chilkoti A: Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond). 5:793–806. 2010. View Article : Google Scholar : PubMed/NCBI
19	Fang H, Feng Q, Shi Y, Zhou J, Wang Q and Zhong L: Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate. Mol Cell Endocrinol. 501:1106602020. View Article : Google Scholar
20	Do MH, Phan NH, Nguyen TD, Pham TT, Nguyen VK, Vu TT and Nguyen TK: Activated carbon/Fe(3)O(4) nanoparticle composite: Fabrication, methyl orange removal and regeneration by hydrogen peroxide. Chemosphere. 85:1269–1276. 2011. View Article : Google Scholar : PubMed/NCBI
21	Deng Z, Rong Y, Teng Y, Mu J, Zhuang X, Tseng M, Samykutty A, Zhang L, Yan J, Miller D, et al: Broccoli-Derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-Activated protein kinase. Mol Ther. 25:1641–1654. 2017. View Article : Google Scholar : PubMed/NCBI
22	Dashamiri S, Ghaedi M, Asfaram A, Zare F and Wang S: Multi-response optimization of ultrasound assisted competitive adsorption of dyes onto Cu (OH)2-nanoparticle loaded activated carbon: Central composite design. Ultrason Sonochem. 34:343–353. 2017. View Article : Google Scholar
23	Hou X, Lin H, Zhou X, Cheng Z, Li Y, Liu X, Zhao F, Zhu Y, Zhang P and Chen D: Novel dual ROS-sensitive and CD44 receptor targeting nanomicelles based on oligomeric hyaluronic acid for the efficient therapy of atherosclerosis. Carbohydr Polym. 232:1157872020. View Article : Google Scholar : PubMed/NCBI
24	Li S, Luo L, He Y, Li R, Xiang Y, Xing Z, Li Y, Albashari AA, Liao X, Zhang K, et al: Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 54:e130932021. View Article : Google Scholar : PubMed/NCBI
25	He F and Zuo L: Redox roles of reactive oxygen species in cardiovascular diseases. Int J Mol Sci. 16:27770–27780. 2015. View Article : Google Scholar : PubMed/NCBI
26	Kwon JH, Lee NG, Kang AR, Ahn IH, Choi IY, Song JY, Hwang SG, Um HD, Choi JR, Kim J, et al: JNC-1043, a novel podophyllotoxin derivative, exerts anticancer drug and radiosensitizer effects in colorectal cancer cells. Molecules. 27:2022. View Article : Google Scholar
27	Behera SS, Pramanik K and Nayak MK: Recent advancement in the treatment of cardiovascular diseases: Conventional therapy to nanotechnology. Curr Pharm Des. 21:4479–4497. 2015. View Article : Google Scholar : PubMed/NCBI
28	Yoshida K, Ono T, Dairaku T, Kashiwagi Y and Sato K: Preparation of hydrogen peroxide sensitive nanofilms by a Layer-by-Layer technique. Nanomaterials (Basel). 8:9412018. View Article : Google Scholar : PubMed/NCBI
29	Kumari P, Rompicharla SVK, Muddineti OS, Ghosh B and Biswas S: Transferrin-anchored poly(lactide) based micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids. Int J Biol Macromol. 116:1196–1213. 2018. View Article : Google Scholar : PubMed/NCBI
30	Kiran Rompicharla SV, Trivedi P, Kumari P, Ghanta P, Ghosh B and Biswas S: Polymeric micelles of suberoylanilide hydroxamic acid to enhance the anticancer potential in vitro and in vivo. Nanomedicine (Lond). 12:43–58. 2017. View Article : Google Scholar
31	Son GM, Kim HY, Ryu JH, Chu CW, Kang DH, Park SB and Jeong YI: Self-assembled polymeric micelles based on hyaluronic acid-g-poly(D,L-lactide-co-glycolide) copolymer for tumor targeting. Int J Mol Sci. 15:16057–16068. 2014. View Article : Google Scholar : PubMed/NCBI
32	Luo L, He Y, Jin L, Zhang Y, Guastaldi FP, Albashari AA, Hu F, Wang X, Wang L, Xiao J, et al: Application of bioactive hydrogels combined with dental pulp stem cells for the repair of large gap peripheral nerve injuries. Bioact Mater. 6:638–654. 2021.
33	Oerlemans C, Bult W, Bos M, Storm G, Nijsen JF and Hennink WE: Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm Res. 27:2569–2589. 2010. View Article : Google Scholar : PubMed/NCBI
34	Nam SH, Lee SW, Lee YJ and Kim YM: Safety and tolerability of weekly Genexol-PM, a Cremophor-Free polymeric micelle formulation of paclitaxel, with carboplatin in gynecologic cancer: A phase I study. Cancer Res Treat. 55:1346–1354. 2023. View Article : Google Scholar : PubMed/NCBI
35	Liu Y, Liu Y, Zang J, Abdullah AAI, Li Y and Dong H: Design strategies and applications of ROS-Responsive phenylborate Ester-based nanomedicine. ACS Biomater Sci Eng. 6:6510–6527. 2020. View Article : Google Scholar : PubMed/NCBI
36	Yoshida K, Awaji K, Shimizu S, Iwasaki M, Oide Y, Ito M, Dairaku T, Ono T, Kashiwagi Y and Sato K: Preparation of microparticles capable of glucose-induced insulin release under physiological conditions. Polymers (Basel). 10:11642018. View Article : Google Scholar
37	Council NR, Earth Do, Studies L, Research IfLA, Care CftUotGft and Animals UoL: Guide for the care and use of laboratory animals. 2010.
38	Ovsianikov A, Deiwick A, Van Vlierberghe S, Dubruel P, Moller L, Drager G and Chichkov B: Laser fabrication of three-dimensional CAD scaffolds from photosensitive gelatin for applications in tissue engineering. Biomacromolecules. 12:851–858. 2011. View Article : Google Scholar : PubMed/NCBI
39	Oommen OP, Duehrkop C, Nilsson B, Hilborn J and Varghese OP: Multifunctional hyaluronic acid and chondroitin sulfate nanoparticles: Impact of glycosaminoglycan presentation on receptor mediated cellular uptake and immune activation. ACS Appl Mater Interfaces. 8:20614–20624. 2016. View Article : Google Scholar : PubMed/NCBI
40	Neves AR, Queiroz JF, Costa Lima SA, Figueiredo F, Fernandes R and Reis S: Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery. J Colloid Interface Sci. 463:258–265. 2016. View Article : Google Scholar
41	Zamani E, Johnson TJ, Chatterjee S, Immethun C, Sarella A, Saha R and Dishari SK: Cationic π-Conjugated polyelectrolyte shows antimicrobial activity by causing lipid loss and lowering elastic modulus of bacteria. ACS Appl Mater Interfaces. 12:49346–49361. 2020. View Article : Google Scholar : PubMed/NCBI
42	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
43	Van Poucke C, Verdegem E, Mangelinckx S and Stevens CV: Synthesis and unambiguous NMR characterization of linear and branched N-alkyl chitosan derivatives. Carbohydr Polym. 337:1221312024. View Article : Google Scholar : PubMed/NCBI
44	Burns J, Wilding CP, L Jones R and H Huang P: Proteomic research in sarcomas-current status and future opportunities. Semin Cancer Biol. 61:56–70. 2020. View Article : Google Scholar :
45	Musat V, Anghel EM, Zaharia A, Atkinson I, Mocioiu OC, Busila M and Alexandru P: A Chitosan-Agarose Polysaccharide-Based hydrogel for biomimetic remineralization of dental enamel. Biomolecules. 11:11372021. View Article : Google Scholar : PubMed/NCBI
46	Yuan Z, Nie H, Wang S, Lee CH, Li A, Fu SY, Zhou H, Chen L and Mao JJ: Biomaterial selection for tooth regeneration. Tissue Eng Part B Rev. 17:373–388. 2011. View Article : Google Scholar : PubMed/NCBI
47	Feng P, Wu P, Gao C, Yang Y, Guo W, Yang W and Shuai C: A multimaterial scaffold with tunable properties: Toward bone tissue repair. Adv Sci (Weinh). 5:17008172018. View Article : Google Scholar : PubMed/NCBI
48	Li CJ, Liu XZ, Zhang L, Chen LB, Shi X, Wu SJ and Zhao JN: Advances in bone-targeted drug delivery systems for neoadjuvant chemotherapy for osteosarcoma. Orthop Surg. 8:105–110. 2016. View Article : Google Scholar : PubMed/NCBI
49	Mauro N, Utzeri MA, Cillari R, Scialabba C, Giammona G and Cavallaro G: Cholesterol-Inulin conjugates for efficient SN38 nuclear delivery: Nanomedicines for precision cancer therapy. Cancers (Basel). 14:48572022. View Article : Google Scholar : PubMed/NCBI
50	Song H, Li H, Shen X, Liu K, Feng H, Cui J, Wei W, Sun X, Fan Q, Bao W, et al: A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma. Acta Biomater. 177:456–471. 2024. View Article : Google Scholar : PubMed/NCBI
51	Wang X, Wu J, Lv R, Bai Y, Wang C, Zhang F and Liu Z: Bioinspired hydrogen peroxide-activated nanochannels and their applications in cancer cell analysis. Anal Chem. 94:6234–6241. 2022. View Article : Google Scholar : PubMed/NCBI
52	Ma L, Zou X and Chen W: A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol. 10:1501–1508. 2014. View Article : Google Scholar : PubMed/NCBI
53	Marosfoi MG, Korin N, Gounis MJ, Uzun O, Vedantham S, Langan ET, Papa AL, Brooks OW, Johnson C, Puri AS, et al: Shear-Activated nanoparticle aggregates combined with temporary endovascular bypass to treat large vessel occlusion. Stroke. 46:3507–3513. 2015. View Article : Google Scholar : PubMed/NCBI
54	Meng Y, Chen S, Wang C and Ni X: Advances in composite biofilm biomimetic nanodrug delivery systems for cancer treatment. Technol Cancer Res Treat. 23:153303382412502442024. View Article : Google Scholar : PubMed/NCBI